RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. BB Biotech
B

BB Biotech portfolio

BB Biotech has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Matchpoint Therapeutics's $150M Series B+ round in October 2026, alongside T1D Fund, Sanofi Ventures, Norwest Venture Partners and 6 others. That company is in Health and bio.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $150M.
Latest deal: Matchpoint Therapeutics · Oct 7, 2026.

What BB Biotech invests in

How BB Biotech invests

StageDealsCapital in rounds
Series B+ 1 100%$150M

Share is of the 1 round on Recent Funding that name BB Biotech. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

BB Biotech portfolio companies

CompanyRound with BB BiotechTotal raisedLatest raise
MMatchpoint Therapeutics
Health and bio
Series B+ · $150M$250MOct 7, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists BB Biotech, which is a subset of its real portfolio. API: /api/v1/investors/bb-biotech (get a free API key). More: the most active VC firms and new venture capital funds.